Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeted α-synuclein mRNA degradation by PMO-based RNA-degrading chimeras.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

A Randomized Controlled Trial of Dual Upper-Extremity Training [DUET]: Combining Neurologic Music Therapy® with Noninvasive Brain Stimulation for Upper-Limb Performance in Corticobasal Syndrome.

Movement disorders clinical practice·2026
Same author

CGRP-Targeting Therapies in Vestibular Migraine: A Synthesis of Observational Evidence with Direction-of-Effect Analysis.

Medical sciences (Basel, Switzerland)·2026
Same author

Trajectories of brain structure and function in young adult carriers of genetic frontotemporal dementia variants.

medRxiv : the preprint server for health sciences·2026
Same author

Why diabetes matters in dementia studies: Excluding diabetes status masks regional mitochondrial DNA copy number changes in human hippocampus, amygdala, and cerebellum in Alzheimer's disease.

bioRxiv : the preprint server for biology·2026
Same author

Deciphering Freezing of Gait: What Neuropathology Reveals About an Episodic Phenomenon.

The European journal of neuroscience·2026

Related Experiment Video

Updated: Jan 11, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.9K

Multiple System Atrophy Without Dysautonomia: An Autopsy-Confirmed Study.

Ida Wilkens1, Sarah Bebermeier2, Johanne Heine3

  • 1Department of Neurology, LMU University Hospital, Ludwig-Maximilians-Universität (LMU) München, Munich, Germany.

Neurology
|November 13, 2025
PubMed
Summary

Multiple system atrophy (MSA) patients without autonomic symptoms may have a slower disease progression. This motor-only subgroup, identified by new criteria, is crucial for future natural history and interventional studies.

More Related Videos

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

33.1K
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.1K

Related Experiment Videos

Last Updated: Jan 11, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.9K
Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

33.1K
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.1K

Area of Science:

  • Neurology
  • Neurodegenerative Diseases

Background:

  • Multiple system atrophy (MSA) is a neurodegenerative disorder with parkinsonism, cerebellar syndrome, and dysautonomia.
  • Recent Movement Disorder Society (MDS) criteria permit MSA diagnosis based on motor symptoms alone, excluding the need for autonomic dysfunction.

Purpose of the Study:

  • To investigate the frequency and disease trajectory of MSA patients lacking dysautonomia.
  • To compare the clinical course of MSA patients without dysautonomia to those with autonomic involvement.

Main Methods:

  • Analysis of a multicenter cohort of autopsy-confirmed MSA patients.
  • Categorization using MDS-MSA criteria and tracking of symptom evolution.
  • Matching of motor-symptom-only patients with those exhibiting dysautonomia for comparison.

Main Results:

  • 58% of 140 MSA patients initially presented without dysautonomia.
  • Patients without dysautonomia had a significantly longer disease duration (8.1 years) compared to those with dysautonomia (6.3 years).
  • Cerebellar onset MSA progressed faster to multisystem involvement than parkinsonian onset MSA.

Conclusions:

  • The MDS-MSA criteria identify a motor-only subgroup with a distinct, potentially slower disease course.
  • Including motor-only MSA patients in research is vital for understanding natural history and developing interventions.
  • Retrospective data collection and symptom documentation variability are study limitations.